This opportunity is currently closed.
Sign up for Content Alerts to stay informed when this or related funding opportunities are posted.
2022-2024 SITC-BMS Translational Fellowship Award (cancer immunotherapy worldwide)
The 2022-2024 SITC-BMS Translational Fellowship Award from the Society for Immunotherapy of Cancer (SITC) is funded by Bristol Myers Squibb (BMS) and supports a postdoctoral researcher, resident, research scientist, or comparable position, working on research and translation of immunotherapeutic approaches. Applicants must be a member of the SITC and hold an MD, PhD or MD/PhD degree. Applications are open to candidates worldwide. The fellowship provides funding of 200,000 USD over 2 years plus financial support to attend SITC´s 37th Annual Meeting. Applications close on April 5, 2022.
Create or sign in to your free account for more functionalities, including a full display of the eligibility criteria such as location and citizenship requirements.